Business Services Industry

Venezuela: Aventis Pharma predicts US$70mil sales.

South American Business Information, January, 2000

Aventis Pharma, the company created from the merge of Hoechst and Rhone Poulenc, plans to win over the next 12 months a 6% share in the Venezuelan drugs & pharmaceuticals market where it currently has 5,6% and sales of US$70mil. Chairman Mr. Ulrich Steuer explained focus will be in pharmaceuticals and vaccines, produced in a plant at Guerenas thatis receiving investments of US$20mil and is producing 30mil units py, 50% earmarked to internal sales. This unit is to be fully completed by mid 2000. The company has 540 employees in Venezuela, where it is investing US$500,000 in advertising, and from Caracas it will coordinated operations in the Andean market, Central America, and the Caribbean.

Source: El Nacional Page: 1 Date: January 21, 2000 Country:...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement